Labroplasty in Cases of Anterior Shoulder Instability With Subcritical Glenoid Bone Loss

March 17, 2026 updated by: Sherif Walid Mohamed Shebl Ibrahim, Kasr El Aini Hospital

The goal of this clinical trial is to learn Labroplasty using the long head of biceps tendon works to patients with recurrent anterior shoulder instability with subcritical glenoid bone loss (<20%) and thinned or deficient anterior labrum .The main questions it aims to answer are:

Does Labroplasty using the long head of biceps improve the functional and radiological outcomes in patients with recurrent anterior shoulder instability with subcritical glenoid bone loss?

Participants will:

undergo arthroscopic labroplasty using the long head of biceps tendon Visit the clinic regularly for checkup and followup undergo MRI at 6 months to check radiological outcome

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

21

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Sherif Walid Ibrahim, Assistant Lecturer
  • Phone Number: 002 +201271377782
  • Email: sherif_shibl@yahoo.com

Study Locations

  • Egypt
    • Cairo Governorate
      • Cairo, Cairo Governorate, Egypt
        • Recruiting
        • Kasr El Aini Hospital
        • Contact:
        • Principal Investigator:
          • sherif Walid Ibrahim, Assistant Lecturer

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • patients with recurrent anterior shoulder instability with one or more events of anterior shoulder dislocation.
  • Franceschi types 2 and 3 labral defects
  • subcritical glenoid bone loss <20%
  • positive anterior shoulder apprehension

Exclusion Criteria:

  • Critical glenoid bones loss >20%
  • Franceschi type 1 labral defect
  • concomitant long head of biceps tendon pathology
  • multidirectional instability
  • prior arthroscopic shoulder stabilization surgery
  • concomitant proximal humeral fractures
  • concomitant Rotator cuff tears
  • skeletally immature patients
  • glenoid pathology
  • Shoulder arthritis
  • active infection

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: patients with recurrent anterior shoulder instability with subcritical glenoid bone loss
Arthroscopic All-inside labroplasty using long head of biceps tendon in patients with recurrent anterior shoulder instability with subcritical glenoid bone loss (<20%) and thinned or deficient anterior labrum
Procedure: Arthroscopic Labroplasty using long head of biceps tendon
Arthroscopic All-inside labral reconstruction using the long head of biceps tendon

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Change in Modified Rowe score postoperative
Time Frame: Assessed preoperative , then at 6 months and 12 months postoperative
Assessed preoperative , then at 6 months and 12 months postoperative

Secondary Outcome Measures

Outcome Measure
Time Frame
Constant shoulder score
Time Frame: assessed preoperative , then at 6 months and 12 months postopertive
assessed preoperative , then at 6 months and 12 months postopertive

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Kasr El Aini Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2026

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2027

Study Registration Dates

First Submitted

March 12, 2026

First Submitted That Met QC Criteria

March 17, 2026

First Posted (Actual)

March 23, 2026

Study Record Updates

Last Update Posted (Actual)

March 23, 2026

Last Update Submitted That Met QC Criteria

March 17, 2026

Last Verified

December 1, 2025

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • MD-439-2025

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Recurrent Anterior Shoulder Instability

Clinical Trials on Arthroscopic Labroplasty using long head of biceps tendon

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Luxembourg

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe